Trial to study subcutaneous ICD in patients with diabetes, MI commences - Healio

Trial to study subcutaneous ICD in patients with diabetes, MI commences Healio The study, MADIT S-ICD, will enroll participants aged 65 years and older with a history of prior MI, diabetes and moderately reduced left ventricular ejection fraction to study subcutaneous ICD system (EMBLEM MRI, Boston Scientific). This population is ...